[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 113,013
Sort by:

TAKEDA - Azilva in Japan - Differentiating Will Not Be Easy!

US$ 90.00

... me-too ARB Azilva (Azilsartan) in Japan in May-12; Azilva aims to retain revenue of Takeda’s best selling ARB Blopress that is soon going off patent. Takeda highlights the ...

April 2012 2 pages

Cosmeceuticals in the U.S, 6th Edition

US$ 3,750.00

... growth in 2010 and 4% growth in 2011. This upswing puts U.S. retail sales of cosmeceuticals at $9.7 billion in 2011, with ongoing annual sales gains expected to boost ... completely updated Packaged Facts report examines the market for cosmeceutical products within the context of broader HBC trends in new product ...

April 2012 238 pages

2012 Global Alpha-2 Antiplasmin Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Alpha-2 Antiplasmin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as ...

April 2012 195 pages

2012 Global Antithrombin III Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... III testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the AT III testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as ...

April 2012 197 pages

2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... APTT testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as ...

April 2012 198 pages

2012 Global D-Dimer Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... Dimer testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the D-Dimer testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well ...

April 2012 197 pages

2012 Global Factor Assays Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,800.00

... additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year ...

April 2012 295 pages

2012 Global Fibrinogen Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Fibrinogen testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as ...

April 2012 200 pages

2012 Global Heparin Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Heparin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- ...

April 2012 200 pages

2012 Global Thrombin Time Market Outlook: Test Volume Forecasts by Country and Market Segment

US$ 3,080.00

... additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Thrombin Time testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10- ...

April 2012 196 pages

INCYTE: Cheers for INCY - JAKAVI Receives CHMP Nod!

US$ 90.00

Incyte/ Novartis’ JAKAVI (ruxolitinib, JAK 1/2 inhibitor, Registered for MF; PhII ... triggers $40m milestone payment from Novartis (Ex-US rights), and INCY will received a second payment of $60m upon an achievement ... our report released on April 20, 2012 on INCY, titled “Cheers for INCY - JAKAVI Receives CHMP Nod!”

April 2012 2 pages

Medicated Skin Care in Hong Kong, China

US$ 990.00

... occurrences of skin diseases or symptoms in Hong Kong will continue to see growth in medicated skin care due to stressful lifestyle, diseases, erratic weather conditions, etc. Euromonitor International's Medicated Skin Care in Hong Kong, China ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 20 pages

Medicated Skin Care in Ecuador

US$ 990.00

... any measures to prevent the consequences. This has... Euromonitor International's Medicated Skin Care in Ecuador report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 22 pages

Thailand Medical Tourist Arrivals, Medical Tourism Market & Forecast to 2015

US$ 800.00

Thailand is the leader in medical tourist arrivals holding more than 40% share in Asia medical tourist arrivals in 2011. Its medical tourism market was around US$ 2 Billion in 2011 and it is expected...

April 2012 41 pages

Medicated Skin Care in Belarus

US$ 990.00

... . Rising urban population and stress levels in Belarus also resulted in an increase in the incidence of skin... Euromonitor International's Medicated Skin Care in Belarus report offers a comprehensive guide to the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 35 pages

Weight Management in Belarus

US$ 900.00

... to obesity products, which are only available in... Euromonitor International's Weight Management in Belarus report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the Weight Management market; Pinpoint growth sectors and identify factors driving ...

April 2012 23 pages

Medicated Skin Care in Turkey

US$ 990.00

... are usually cosmetic products rather than medicines. Euromonitor International's Medicated Skin Care in Turkey report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 28 pages

Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

US$ 3,700.00

... to Susan Eustis, lead author of the study, 'Reimbursement drives power wheelchair markets'. As people and governments pay for medical insurance more money ... , permitting the patient to control mobility for the rehabilitation efforts. Power wheel chairs give patients the ability to control movement. Transport ...

April 2012 467 pages

REGENERON: Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!

US$ 90.00

... with Bayer for Ex-US, wet AMD) launch skyrocketed Regeneron (REGN); we expect other TRAP based products in the pipeline to sustain this ... Sanofi granted A Priority Review for ZALTRAP (VEGF trap/ aflibercept, R, mCRC – 2nd-line; PhII/ ... 5, 2012 on REGN, titled “Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!”

April 2012 5 pages

Medicated Skin Care in France

US$ 990.00

... drugs and Rx medicines because they are reimbursed. Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 42 pages

Medicated Skin Care in the US

US$ 990.00

... diapers, which increases the incidence of diaper rash. Euromonitor International's Medicated Skin Care in USA report offers a comprehensive guide to the size and shape ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 53 pages

Healthcare Industry Deal Directory - Edition Q4'2011

US$ 350.00

The healthcare database provides access to all the Mergers and Acquisitions (M&A), Private Equity and Venture Capital Deals since 2004. The database is categorized into various sub-sectors includi...

April 2012

HARMONY 6 – Albiglutide Non-inferior on Efficacy to Humalog on top of Lantus, but competition better positioned to tap this market

US$ 90.00

GSK reported that topline data from Harmony 6 study met the primary end point. Albiglutide produced clinically significant reductions in HbA1c vs. ... Lantus after 26 wks of treatment. We do not see meaningful potential for albiglutide in the insulin population as the competition (IdegLira and Lyxumia-Lantus ...

April 2012 4 pages

Novartis, GSK - QVA149- Most Advanced once daily LABA+LAMA: Data positive but Competition follows closely

US$ 90.00

... ) exploring the efficacy and safety of QVA149. In the SHINE study (26 wk, n=2100), QVA149 showed statistically superior FEV1 reduction in comparison ... moderate to severe COPD patients. In a smaller BRIGHT study (3 wk), QVA149 demonstrated significant improvement in exercise endurance against placebo and in the ...

April 2012 2 pages

Healthcare Distribution and Services Industry in the US – PEST Framework Analysis

US$ 175.00

... , and other pharmaceuticals outlets. Aruvian's R'search analyzes the Healthcare Distribution and Services Industry in the United States in a PEST Framework Analysis. A PEST analysis is concerned with ...

April 2012 20 pages

Global Home Healthcare Device Industry 2012 - 2017: Trend, Profit, and Forecast Analysis

US$ 1,980.00

... the face of global home healthcare device industry. Lucintel’s study provides a concise overview of the global home healthcare device industry. The report tracks four regions of global home healthcare device industry. This study ... ) for global home healthcare device industry analysis Gross and net profit trends in the global home healthcare device industry analysis Cost structure trend in the global as well as regional home healthcare device industry ...

April 2012

UAE Healthcare Sector Forecast to 2014

US$ 1,200.00

In the past few years, the UAE healthcare industry has shown an unprecedented growth which is expected to continue in the future due to increasing population, rising prevalence of lifestyle diseases a...

March 2012 135 pages

Saudi Arabian Healthcare Forecast to 2015

US$ 1,000.00

Saudi Arabia represents the largest healthcare market in the GCC region that possesses a huge potential for further expansion due to rising healthcare needs. The government and health regulatory autho...

March 2012 115 pages

G-Protein Coupled Receptors (GPCRs): Market Research Report

US$ 4,500.00

This report analyzes the Global market for G-Protein Coupled Receptors (GPCRs) in US$ Billion. Annual estimates and forecasts are provided for ... through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 43 companies including 7TM Pharma A/S, Actelion Pharmaceuticals ...

March 2012 299 pages

Global RNAi Market Analysis

US$ 1,200.00

RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic app...

March 2012 105 pages

Herpes Simplex Virus Treatment: Market Research Report

US$ 4,600.00

This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...

March 2012 300 pages

Global Protein Therapeutics Market Forecast to 2015

US$ 1,800.00

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...

March 2012 160 pages

Therapy Trends: Multiple Sclerosis

US$ 4,995.00

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...

March 2012 160 pages

Market Access: Communicating Value Stories to Payers

US$ 595.00

... affiliate organisations. What strategies are emerging to tackle these challenges? Market Access: Communicating Value Stories to Payers shares up-to-the-minute insights and case studies from ... finding their way through this new environment. Report Overview Market Access: Communicating Value Stories to Payers provides unique, practical insights into how companies can ...

March 2012 46 pages

TOP TEN ANDA / PARA-IV / API OPPORTUNITIES TO BE TARGETED BY GENERIC OR ACTIVE PHARMACEUTICAL INGREDIENT COMPANIES

US$ 5,000.00

... of the 10 products screened, nine have not yet been targeted by Para-IV filer. The products selected span across four therapy areas ...

March 2012 60 pages

Roche - GSK - EMILIA: TDM1 ready to take over Tykerb

US$ 90.00

Today, Roche and ImmunoGen announced the topline data from EMILIA study ... T-DMI in this indication and this should come at the expense of GSK’s Tykerb, which is the current standard of care in this setting. This ...

March 2012 3 pages

Opportunities in the Telemedicine Market in India

US$ 1,000.00

Executive The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations. The...

March 2012 30 pages

Merck - IMPROVE IT update - Appears trending favorably

US$ 90.00

Today, Merck announced that the Data Safety Monitoring Board has given a go-ahead signal to the IMPROVE-IT after it conducted a pre-specified second interim ... . The company has also indicated that the projected completion of IMPROVE IT by 2013 may change.

March 2012 1 pages

BMY, EINSTEIN PE: Needle-free single drug approach with no monitoring issue - Safer

US$ 90.00

At ACC, Bayer reported clinical data from EINSTEIN-PE study which compared the safety and effectiveness of Xarelto in the ... of anti-coagulant therapy for their acute episode of VTE (EINSTEIN-EXT Trial). In the EINSTEIN-EXT trial, after a mean treatment of 190 days ...

March 2012 2 pages

Medicated Skin Care in Argentina

US$ 990.00

... out of every 10 Argentine women in the country wear... Euromonitor International's Medicated Skin Care in Argentina report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

March 2012 30 pages

CHUGAI - Hefty Price Cut on Actemra Owing to Exceeding Projected Sales - Slightly Negative!

US$ 90.00

... is expected to be slightly negative. Apart from this, the overall impact of price cuts on Chugai is expected to be at par with industry i.e. ~6%. The reason for this ... NIH price of new drugs. Actemra has been very successful in RA since its launch in Japan in 2008 and remains a key growth driver for Chugai.

March 2012 3 pages

Medicated Skin Care in Estonia

US$ 990.00

Medicated skin care witnessed current value growth of 5% to reach EUR1.6 million in 2011 due to increased consumption. Consumers purchased medicated skin care products more freely in 2011 because ... decreased as well. Due to many positive factors, consumers’... Euromonitor International's Medicated Skin Care in Estonia report offers a comprehensive guide to the size and shape of the ...

March 2012 23 pages

Medicated Skin Care in Russia

US$ 990.00

... consultations with cosmetologists, trichologists and other professionals on... Euromonitor International's Medicated Skin Care in Russia report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

March 2012 43 pages

NATCO PHARMA- Entering the Big League through Multi Pronged Strategy

US$ 140.00

... ready to be filed for compulsory licenses. Natco has one of the most lucrative Para IV pipeline in India pharma currently with Para IVs on Copaxone ($2.8b in US), Revlimid ...

March 2012 10 pages

Fitness & Slimming Industry in India (2011-15)

US$ 500.00

EXECUTIVE SUMMARY Indian Fitness & Slimming Industry constitutes about 8% of the wellness market. Presently, the fitness industry is in its nascent stages. The industry is fairly fragmented...

March 2012 48 pages

The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

US$ 3,995.00

... . These twin challenges are addressed in The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living The report ... the Marketplace Competitors and Competitive Analysis Sales estimates for each market segment represent U.S. revenues and are expressed in current dollars. Estimates ...

March 2012 185 pages

Medicated Skin Care in Lithuania

US$ 990.00

... little hesitation about spending on medicines recommended by a dermatologist. Euromonitor International's Medicated Skin Care in Lithuania report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

March 2012 27 pages

Medicated Skin Care in Denmark

US$ 990.00

Medicated skin care grew by 1% in 2011 to reach sales of DKr144 million. The positive growth stemmed from consumers’ increasing willingness to self-medicate and cure their skin ... ) treatments and cold sore treatments are skin conditions that most sufferers... Euromonitor International's Medicated Skin Care in Denmark report offers a comprehensive guide to the size ...

March 2012 32 pages

Medicated Skin Care in New Zealand

US$ 990.00

... hundreds of regulations that are considered to hinder business practice in New Zealand. With regard to medicated skin care, this review was intended to reduce compliance costs for ... Regulations Act 1984 as ‘a product that is primarily a food,... Euromonitor International's Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the ...

March 2012 36 pages

Medicated Skin Care in Bolivia

US$ 990.00

... from. This trend continued to drive demand for medicated skin care products in 2011. Euromonitor International's Medicated Skin Care in Bolivia report offers a comprehensive guide to the size and ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...

March 2012 30 pages

Filters

Search

Categories

370
94
241
549
1,146
110,519
94

Publishers

179
1
100
35
25
102
95
2,316
177
23
40
8,299
68
562
988
34
29,954
248
501
3,036
1
1
2
3
1
16
257
537
361
106
1
1,357
2,180
60
1,696
8
8,921
1,816
4
3,712
983
19
1
321
4,852
2,743
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
274
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
33
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
487
1
4
6
1
3
9
1
3
5
1
1
1
90
2
3
4
1
81
15
1,008
1
3
1
17
227
128
16
4
412
3
74
2
6
5
10
1
3
118
33
336
197
47
474
7
45
1
22
13
138
2
4

Regions

58
48
35
31
30
29
29
26
26
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
36
57
41
51
57
98
26
30
52
3
34
2
2
1,178
115
172
26
33
94
14
49
44
28
18
59
25
23
39
23
40
24
14
51
28
35
130
47
65
64
199
49
17
53
39
31
45
44
37
33
19
56
147
34
31
28
17
17
16
14
133
54
46
30
15
457
1,819
68
1,614
921
765
181
2,005
100,410

Price

Date

Pages

Offers

94
23
905
1
2,730
273
1
1